Enhanced plasticity and metabolic redundancy have been previously observed in CB-839-resistant breast cancer 63, 64, although the precise mechanisms of glutaminase inhibition resistance in CRC remain understudied. The gene discussed is GLS; the disease is breast carcinoma.